Blog

Xcell Biosciences Announces New Emphasis Towards Immunotherapy Markets and Expands Leadership Team – Business Wire (press release)

Xcell Biosciences Announces New Emphasis Towards Immunotherapy Markets and Expands Leadership Team
Business Wire (press release)
SAN FRANCISCO–(BUSINESS WIRE)–Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development. The ever-growing Immuno-Oncology landscape and

and more »

2018-01-04 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.